CXCL12-(1-9) [2556]
CXCL12-(1-9)
| SMILES | CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O |
| InChIKey | LDJISKZMVNIUHX-VXJRNSOOSA-N |
| Sequence | KPVSLSYRC |
| HELM | PEPTIDE1{K.P.V.S.L.S.Y.R.C}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 16 |
| Hydrogen bond donors | 16 |
| Rotatable bonds | 32 |
| Log P | -4.470 |
| Molecular weight (Da) | 1051.5 |
| Stereochemistry info | unspecified |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
CXCL12-(1-9)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0